Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
03 May 2019 | Story Ruan Bruwer
Lynique Beneke
Lynique Beneke, long jump athlete of the University of the Free State and the national women’s champion seven times in a row, hopes to qualify for the World Championships.

The long jumper, Lynique Beneke, dreams of going to another Olympic Games and jumping over seven metres before she retires.

In between, there is still a World Championship later in the year for which she is trying to qualify. The qualifying standard is 6,72 m, not far from the 6,64 m she achieved at the national athletics championships at the end of April, which earned her a seventh consecutive national crown. At the time, it was the seventh best globally. She will have to qualify in Europe, as the South African season is over.

“With my faith as my biggest support, my mom and I both dreamed about me jumping exactly the same distance of 7,03 m! That is my big goal. I know I can do that,” Beneke (28) said. Her personal best is 6,81 m.

Special bond with coach


She is currently studying Education (BEd Senior and FET phase). “At this moment, I’m focusing on finishing my degree and enjoying my athletics. I want to give my athletics a fair chance, as I am only getting into prime shape now at this age. Once I’m done with athletics, I will focus on a career.”

According to Beneke, a 2016 Olympian and the Kovsie Senior Sportswoman of the Year for 2018, consistency is the name of her game. “I show up, even when I don’t feel like it. I push myself every day. I feel I have so much left in the tank, and that motivates me. All the glory to God.”

She is married to the hurdler, PC (also a Kovsie student). They moved from Gauteng to Bloemfontein at the end of 2017.

“My coach, Emmarie Fouché, was the big influence (coming here). I started working with her at the end of 2015. We work perfectly together; we are both women and have the same work ethic. She understands me. We are very close, and I think that is what makes the difference.”


News Archive

Heart-valve studies receive international recognition
2017-07-11

 Description: Heart-valve studies  Tags: Heart-valve studies  

Prof Francis Smit, Head of the Department of
Cardiothoracic Surgery at the UFS, and Manager of the
Robert WM Frater Cardiovascular Research Centre, with
Kyle Davis, Mechanical Engineer at the centre.

Photo: Rulanzen Martin

Three heart-valve studies which have been developed at the Robert WM Frater Cardiovascular Research Centre at the School of Medicine at the University of the Free State (UFS) were recently presented in Monte Carlo at the conference of the prestigious global Heart Valve Society (HVS).

These studies are all headed by Prof Francis Smit, Head of the Department of Cardiothoracic Surgery at the UFS, and Manager of the Robert WM Frater Cardiovascular Research Centre.
Prof Smit says the HVS is a combination of the former heart-valve societies of Europe and the US. “Studies on heart-valve disease, heart-valve-related products and operations, as well as the design and development of new valves were presented. There are both clinical and development divisions.

He says the study in which the hemodynamics of their redesigned mechanical poppet valve was compared to a commercial bi-leaflet mechanical heart valve, was named as the best poster presentation in the experimental valve development and numerical flow dynamics division. The study, which was presented by Kyle Davis, mechanical engineer at the centre, competed against some of the best heart-valve research units in the world.

The redesigned valve, based on the 1960s Cape Town poppet valve, has the potential to provide a low-cost solution for mechanical heart-valve replacement. It is possible to produce the titanium ring with 3-D printers and is, together with the silicon poppet valve, extremely inexpensive compared to current mechanical valve-manufacturing processes.
The advantages of this valve over current mechanical valves is that, due to the effective and laminar flow characteristics, as well as the simple locking mechanisms, there is a reduced chance of valve thrombosis, and the need for anti-clotting drugs is therefore limited.

It was also confirmed that the new valve more than meets the published FDA (Federal Drug Agency) requirements, which determine the minimum standards of valves for human use in the US.

The redesigned valve also has a very low platelet activation impact, which is responsible for platelet thrombosis and leads to valve thrombosis or strokes. This valve is another heart-valve project by the centre, which is also in the process of evaluating a tri-leaflet polyurethane valve developed by them.


We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept